Mercedes Martín-López
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mercedes Martín-López has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- José Francisco Navarro
Department of Psychobiology, School of Psychology, University of Málaga, Spain
15 shared publications Estrella Burón
7 shared publications- Vanessa De Castro
Centre de Recherche Cerveau et Cognition, Université de Toulouse, CNRS, Toulouse, France
3 shared publications José Francisco Navarro
University of Malaga
2 shared publications- Carmen Pedraza
Departamento de Psicobiología y Metodología de las Ciencias del Comportamiento, Universidad de Málaga, Málaga, Spain
1 shared publication Diana Postigo
Department of Psychobiology, Faculty of Psychology, Campus de Teatinos s/n, University of Málaga, 29071 Málaga, Spain
1 shared publication
Latest Publications
- 1 February 2017
- Published by Springer Nature in Pharmacological Reports
- Vol. 69 (1) , 97-104
Selective agonism of mGlu8 receptors by (S)-3,4-dicarboxyphenylglycine does not affect sleep stages in the rat
Metabotropic glutamate receptors (mGlu) play a role in a number of physiological processes and behaviors, as well as in certain pathological conditions and diseases. New drugs targetting mGlu receptors are being developed with treatment purposes. Recent data indicates that glutamate is involved in sleep, and pharmacological manipulation of distinct subtypes of mGlu receptors affect sleep. Here the consequences of selective pharmacological agonism of mGlu8 receptor upon sleep and wakefulness are explored for the first time. 32 male Wistar rats were stereotaxically prepared for polysomnography. (S)-3,4-dicarboxyphenylglycine (S)-3,4-DCPG (5, 10, and 20mg/kg, ip), a selective and potent mGlu8 receptor agonist, or physiological saline was administered one hour after the light period began. Compared to control vehicle, (S)-3,4-DCPG, did not affect, at any of the doses given, the sleep and wakefulness parameters examined in the general analysis of the three hours of recording. Drug effects across time were studied analyzing three one-hour time blocks, control and experimental groups did not show any significant difference in the sleep and wakefulness parameters analyzed. Latency to sleep stages did not significantly vary between vehicle and treatment groups. Results indicate that pharmacological activation of mGlu8 receptor by (S)-3,4-DCPG (5, 10, 20mg/kg, ip) does not affect sleep and wakefulness in the rat, suggesting that pharmacological agonism of these receptors may not influence sleep. Further research is needed to verify whether new drugs acting on these receptors lack of effect upon sleep and wakefulness.
- 1 February 2017
- Published by Springer Nature in Pharmacological Reports
- Vol. 69 (1) , 97-104
Selective agonism of mGlu8 receptors by (S)-3,4-dicarboxyphenylglycine does not affect sleep stages in the rat
Metabotropic glutamate receptors (mGlu) play a role in a number of physiological processes and behaviors, as well as in certain pathological conditions and diseases. New drugs targetting mGlu receptors are being developed with treatment purposes. Recent data indicates that glutamate is involved in sleep, and pharmacological manipulation of distinct subtypes of mGlu receptors affect sleep. Here the consequences of selective pharmacological agonism of mGlu8 receptor upon sleep and wakefulness are explored for the first time. 32 male Wistar rats were stereotaxically prepared for polysomnography. (S)-3,4-dicarboxyphenylglycine (S)-3,4-DCPG (5, 10, and 20mg/kg, ip), a selective and potent mGlu8 receptor agonist, or physiological saline was administered one hour after the light period began. Compared to control vehicle, (S)-3,4-DCPG, did not affect, at any of the doses given, the sleep and wakefulness parameters examined in the general analysis of the three hours of recording. Drug effects across time were studied analyzing three one-hour time blocks, control and experimental groups did not show any significant difference in the sleep and wakefulness parameters analyzed. Latency to sleep stages did not significantly vary between vehicle and treatment groups. Results indicate that pharmacological activation of mGlu8 receptor by (S)-3,4-DCPG (5, 10, 20mg/kg, ip) does not affect sleep and wakefulness in the rat, suggesting that pharmacological agonism of these receptors may not influence sleep. Further research is needed to verify whether new drugs acting on these receptors lack of effect upon sleep and wakefulness.
- 1 January 2017
- Published by Elsevier in Psiquiatría Biológica
- Vol. 24 (1) , 18-23
Papel de la oxitocina en la regulación de la agresión
- 1 January 2017
- Published by Elsevier in Psiquiatría Biológica
- Vol. 24 (1) , 18-23
Papel de la oxitocina en la regulación de la agresión
- 1 January 2010
- Published by Elsevier in Psiquiatría Biológica
- Vol. 17 (1) , 32-36
Papel del glutamato en la regulación de la conducta agresiva en modelos animales
- 1 January 2010
- Published by Elsevier in Psiquiatría Biológica
- Vol. 17 (1) , 32-36
Papel del glutamato en la regulación de la conducta agresiva en modelos animales
- 1 August 2009
- Vol. 21 (3) , 475-9
Behavioural profile of selective ligands for mGlu7 and mGlu8 glutamate receptors in agonistic encounters between mice.
Evidence is accumulating for a role of glutamate transmission in aggression modulation. Recent studies indicate that glutamate metabotropic receptors (mGlu1 and mGlu5) are involved in the regulation of aggressive behaviour. However, to date, the possible role of mGlu7 and mGlu8 receptors has not been explored. In this work, we analyze the effect of acute administration of AMN082 (0.5-4 mg/kg, ip) and (S)-3,4-DCPG (2.5-10 mg/kg, ip), selective ligands for the mGlu7 and mGlu8 receptors, respectively, on agonistic encounters between male mice. Individually housed mice were exposed to anosmic opponents 60 or 30 min after drug administration. Ten min of dyadic interactions were staged between a singly housed and an anosmic mouse in a neutral area. The encounters were videotaped and the accumulated time allocated by subjects to ten broad behavioural categories was estimated using an ethologically based analysis. The highest dose of AMN082 (4 mg/kg) significantly reduced offensive behaviours (threat and attack), as compared with the control group, without depressing motility, whereas (S)-3,4-DCPG did not produce significant behavioural changes. Overall, these results suggest that mGlu7 receptors (but not mGlu8) may be implicated in the modulation of aggression.
- 1 August 2009
- Vol. 21 (3) , 475-9
Behavioural profile of selective ligands for mGlu7 and mGlu8 glutamate receptors in agonistic encounters between mice.
Evidence is accumulating for a role of glutamate transmission in aggression modulation. Recent studies indicate that glutamate metabotropic receptors (mGlu1 and mGlu5) are involved in the regulation of aggressive behaviour. However, to date, the possible role of mGlu7 and mGlu8 receptors has not been explored. In this work, we analyze the effect of acute administration of AMN082 (0.5-4 mg/kg, ip) and (S)-3,4-DCPG (2.5-10 mg/kg, ip), selective ligands for the mGlu7 and mGlu8 receptors, respectively, on agonistic encounters between male mice. Individually housed mice were exposed to anosmic opponents 60 or 30 min after drug administration. Ten min of dyadic interactions were staged between a singly housed and an anosmic mouse in a neutral area. The encounters were videotaped and the accumulated time allocated by subjects to ten broad behavioural categories was estimated using an ethologically based analysis. The highest dose of AMN082 (4 mg/kg) significantly reduced offensive behaviours (threat and attack), as compared with the control group, without depressing motility, whereas (S)-3,4-DCPG did not produce significant behavioural changes. Overall, these results suggest that mGlu7 receptors (but not mGlu8) may be implicated in the modulation of aggression.
- 1 October 2008
- Published by Elsevier in Psiquiatría Biológica
- Vol. 15 (5) , 175-181
Actualización del papel de la enzima MAO-A en la regulación de la conducta agresiva
- 1 October 2008
- Published by Elsevier in Psiquiatría Biológica
- Vol. 15 (5) , 175-181
Actualización del papel de la enzima MAO-A en la regulación de la conducta agresiva
- 1 May 2008
- Published by Elsevier in European Journal of Pharmacology
- Vol. 586 (1-3) , 217-220
JNJ16259685, a selective mGlu1 antagonist, suppresses isolation-induced aggression in male mice
- 1 May 2008
- Published by Elsevier in European Journal of Pharmacology
- Vol. 586 (1-3) , 217-220
JNJ16259685, a selective mGlu1 antagonist, suppresses isolation-induced aggression in male mice
- 1 February 2008
- Vol. 20 (1) , 144-7
Effects of SB-205384, a positive modulator of alpha3-subunit-containing GABA-A receptors, on isolation-induced aggression in male mice.
GABA-A receptors are involved in the control of aggressive behaviour. Various studies suggest a role for a1-containing GABA-A receptors in modulating aggression. However, the possible involvement of a3 subunit of GABA-A receptors has not been examined. In this study, we analysed the effect of SB-205384 (0.5-4 mg/kg, i.p), a positive modulator of GABA-A receptors containing a3 subunit, on agonistic behaviour elicited by isolation in male mice. Half of the mice were housed during 30 days and employed as experimental or control animals; the remainder were used as <> and were temporally rendered anosmic by zinc sulphate. Individually housed mice were exposed to anosmic opponents in a neutral area 30 minutes after the drug administration and encounters were videotaped and evaluated using an ethopharmacologically-based analysis. The results indicated that SB-205384 did not produce any significant behavioural changes, suggesting that GABA-A receptors which contain the a3 subunit may not be involved in the modulation of aggression.
- 1 February 2008
- Vol. 20 (1) , 144-7
Effects of SB-205384, a positive modulator of alpha3-subunit-containing GABA-A receptors, on isolation-induced aggression in male mice.
GABA-A receptors are involved in the control of aggressive behaviour. Various studies suggest a role for a1-containing GABA-A receptors in modulating aggression. However, the possible involvement of a3 subunit of GABA-A receptors has not been examined. In this study, we analysed the effect of SB-205384 (0.5-4 mg/kg, i.p), a positive modulator of GABA-A receptors containing a3 subunit, on agonistic behaviour elicited by isolation in male mice. Half of the mice were housed during 30 days and employed as experimental or control animals; the remainder were used as <> and were temporally rendered anosmic by zinc sulphate. Individually housed mice were exposed to anosmic opponents in a neutral area 30 minutes after the drug administration and encounters were videotaped and evaluated using an ethopharmacologically-based analysis. The results indicated that SB-205384 did not produce any significant behavioural changes, suggesting that GABA-A receptors which contain the a3 subunit may not be involved in the modulation of aggression.
- 1 January 2008
- Published by Elsevier in Psiquiatría Biológica
- Vol. 15 (1) , 11-15
Farmacología y aspectos conductuales del receptor α5/GABA-A
- 1 January 2008
- Published by Elsevier in Psiquiatría Biológica
- Vol. 15 (1) , 11-15
Farmacología y aspectos conductuales del receptor α5/GABA-A
- 1 December 2007
- Published by Elsevier in Psiquiatría Biológica
- Vol. 14 (6) , 199-203
Efectos de la administración de (RS)-2-cloro-5-hidroxifenilglicina (CHPG) sobre la conducta agonística en ratones
- 1 December 2007
- Published by Elsevier in Psiquiatría Biológica
- Vol. 14 (6) , 199-203
Efectos de la administración de (RS)-2-cloro-5-hidroxifenilglicina (CHPG) sobre la conducta agonística en ratones